Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)

NCT00005039 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

86

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage IV Prostate Cancer

Interventions

BIOLOGICAL: recombinant fowlpox-prostate specific antigen vaccine
BIOLOGICAL: recombinant vaccinia prostate-specific antigen vaccine
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)